Pharmaniaga Bhd (7081) - Total Liabilities

Latest as of December 2025: RM1.79 Billion MYR ≈ $448.83 Million USD

Based on the latest financial reports, Pharmaniaga Bhd (7081) has total liabilities worth RM1.79 Billion MYR (≈ $448.83 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 7081 cash flow metrics to assess how effectively this company generates cash.

Pharmaniaga Bhd - Total Liabilities Trend (2012–2025)

This chart illustrates how Pharmaniaga Bhd's total liabilities have evolved over time, based on quarterly financial data. Check 7081 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Pharmaniaga Bhd Competitors by Total Liabilities

The table below lists competitors of Pharmaniaga Bhd ranked by their total liabilities.

Company	Country	Total Liabilities
Beijing Hanjian Heshan Pipeline Co Ltd SHG:603616	China	CN¥1.05 Billion
Lyell Immunopharma Inc NASDAQ:LYEL	USA	$91.85 Million
Jinling Hotel Corp Ltd SHG:601007	China	CN¥1.06 Billion
G-Tech Optoelectronics Corp TW:3149	Taiwan	NT$2.33 Billion
HAXC Holdings (Beijing) Co. Ltd. SHE:300928	China	CN¥144.77 Million
Guangdong Anjubao Digital Tech SHE:300155	China	CN¥138.36 Million
Optiemus Infracom Limited NSE:OPTIEMUS	India	Rs5.73 Billion
Dongsung FineTec Co. Ltd KQ:033500	Korea	₩242.67 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Pharmaniaga Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 7081 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.91	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	4.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.80	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pharmaniaga Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pharmaniaga Bhd (2012–2025)

The table below shows the annual total liabilities of Pharmaniaga Bhd from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	RM1.79 Billion ≈ $448.83 Million	-16.40%
2024-12-31	RM2.14 Billion ≈ $536.84 Million	-2.32%
2023-12-31	RM2.19 Billion ≈ $549.57 Million	-0.30%
2022-12-31	RM2.20 Billion ≈ $551.24 Million	+22.84%
2021-12-31	RM1.79 Billion ≈ $448.76 Million	+43.84%
2020-12-31	RM1.24 Billion ≈ $311.98 Million	-0.94%
2019-12-31	RM1.25 Billion ≈ $314.95 Million	-10.29%
2018-12-31	RM1.40 Billion ≈ $351.09 Million	+29.52%
2017-12-31	RM1.08 Billion ≈ $271.08 Million	-6.31%
2016-12-31	RM1.15 Billion ≈ $289.35 Million	+23.13%
2015-12-31	RM936.00 Million ≈ $235.00 Million	+35.46%
2014-12-31	RM691.00 Million ≈ $173.49 Million	+13.65%
2013-12-31	RM608.00 Million ≈ $152.65 Million	-17.28%
2012-12-31	RM735.00 Million ≈ $184.53 Million	--

About Pharmaniaga Bhd

KLSE:7081 Malaysia Medical Distribution

Market Cap

$403.33 Million

RM1.61 Billion MYR

Market Cap Rank

#13667 Global

#151 in Malaysia

Share Price

RM0.25

Change (1 day)

+0.00%

52-Week Range

RM0.14 - RM0.33

All Time High

RM1.14